The behavior of aprepitant in the stomach, small intestine and blood after the oral administratio

Phase 1

• Conditions: healthy human volunteers (administration of an drug against nausea and vomiting; Therapeutic area: Body processes [G] - Digestive System and Oral Physiological Phenomena [G10]

• Registration Number: EUCTR2016-001156-22-BE
• Lead Sponsor: KU Leuven - Drug Delivery and Disposition

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-06-27
• Last Update Posted: 6 April 2020

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 5

Inclusion Criteria

- healthy volunteers
- age: 18 - 35 years old
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 5
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

- disease
- acute/chronic GI condition
- use of medication
- pregnancy
- frequent exposure to X-rays during the past year
- HIV / HBV / HCV infection

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified